The self-performed test, which won United States emergency use authorisation in December, can give results within 15 minutes or less.
Andy Slavitt, senior adviser for the White House's COVID-19 response, said the Department of Defense and Department of Health and Human Service has awarded $230 million to the company Ellume to bolster the manufacturing and rollout of its rapid at-home nasal test.
Oakland International this week became the first airport in the U.S.to sell COVID-19 test kits in vending machines, according to airport officials.
Slavitt explained that Ellume is ramping up manufacturing and will ship 100,000 test kits per month to the U.S. From February through July, noting "that is good but it is obviously not where we will need to be".
A factory worker in MA undergoes a Covid test before work.
The test is not in use in Australia. The sample is analyzed and results are automatically transmitted to the user's smartphone via Bluetooth.
Ellume's COVID-19 Home Test is a fully at-home diagnostic test that previously received a Food and Drug Administration Emergency Use Authorization for the detection of COVID-19 in individuals with or without symptoms.
When asked how a third vaccine's authorisation could help speed up the government's goal of inoculating most Americans by the end of summer, Mr Slavitt said the authorisation of Johnson & Johnson's shot will not likely cause an immediate dramatic shift.
The kits, made by Wellness 4 Humanity, are designed so travelers can take tests at home before mailing them to a lab and receiving results on an app.
The US now has more than 26.2 million cases of Covid-19, according to Johns Hopkins University data.